Media attention highlights the challenges faced by the rapidly developing field of familial cancer
amilial cancer centres (FCCs) have been established throughout Australia to investigate an individual’s personal and family history of cancer, with the goal of providing familial risk assessment and management advice, and ensuring that the limited resources available for genetic testing are used to maximum benefit. This highly specialised field recently enjoyed a brief moment in the celebrity spotlight when Angelina Jolie, one of the world’s highest profile celebrities, disclosed that she carries a BRCA1 gene mutation and opted to have preventive bilateral mastectomy and breast reconstruction to manage her breast cancer risk. In a thoughtful opinion piece in the New York Times, Jolie discussed her extensive family history and explained how she had come to her own personal choices to manage her risk.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Jolie A. My medical choice. New York Times 2013; 14 May. http://www.nytimes. com/2013/05/14/opinion/my-medical-choice.html (accessed Oct 2013).
- 2. Cancer Australia. Advice about familial aspects of breast cancer and epithelial ovarian cancer. http://canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/advice-about-familial-aspects-breast-cancer-and (accessed Oct 2013).
- 3. Trainer AH, Lewis CR, Tucker K, et al. The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol 2010; 7: 708-717.
We thank Maira Kentwell and Mary-Anne Young for helpful discussions, and Wendy Hertan and Penny Fannin for compiling a Factiva search of print publications. We receive funding from the National Health and Medical Research Council, National Breast Cancer Foundation and Victorian Cancer Agency.
No relevant disclosures.